Home LiteratureArticle Details
PMID: 15659546 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor.

Okumura K, Zhao M, Depinho RA, Furnari FB, Cavenee WK

Abstract

The PTEN (phosphatase and tensin homologue) tumor suppressor protein contains a single catalytic domain with both lipid and protein phosphatase activities. The remaining C-terminal half of the PTEN protein plays a role in its stability and is mutated in many clinical cancer samples. Here, we report that the PTEN C-terminal domain physically interacts with the forkhead-associated domain of the oncogenic MSP58 protein and that this interaction requires PTEN Thr-366. We further show that while MSP58 transforms Pten-/- mouse embryo fibroblasts (MEFs), concurrent introduction of wild-type PTEN causes a dramatic reduction in the number of MSP58-induced transformed foci. This PTEN-mediated inhibition of cellular transformation requires physical interaction as evidenced by the failure of PTEN(T366A) point mutation (residing within the MSP58 interaction domain) to suppress MSP-58-driven transformation. These observations, together with the capacity of catalytically inactive PTEN mutant (G129R) to suppress MSP58 oncogenicity, support the view that the C-terminal region of PTEN directly provides a previously uncharacterized biological function in its ability to regulate cellular transformation.

MeSH Terms
Animals Cell Transformation, Neoplastic Humans Mice Nuclear Proteins/genetics Oncogenes PTEN Phosphohydrolase Phosphatidylinositol 3-Kinases/physiology Phosphoric Monoester Hydrolases/chemistry,physiology RNA-Binding Proteins Tumor Suppressor Proteins/chemistry,physiology
Chemicals
MCRS1 protein, human Nuclear Proteins RNA-Binding Proteins Tumor Suppressor Proteins Phosphatidylinositol 3-Kinases Phosphoric Monoester Hydrolases PTEN Phosphohydrolase PTEN protein, human
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Okumura Koichi
Ludwig Institute for Cancer Research, San Diego Branch, University of California at San Diego, La Jolla, CA 92093-0660, USA.
Zhao Mujun
Depinho Ronald A
Furnari Frank B
Cavenee Webster K
References (18)
18 references, click to expand
  1. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.
    Cancer Res. 1999 Nov 1;59(21):5479-82 PMID: 10554022
  2. Herpes simplex virus 1 regulatory protein ICP22 interacts with a new cell cycle-regulated factor and accumulates in a cell cycle-dependent fashion in infected cells.
    J Virol. 1998 Nov;72(11):8525-31 PMID: 9765390
  3. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.
    Cell. 1999 Oct 29;99(3):323-34 PMID: 10555148
  4. Phosphorylation of the PTEN tail regulates protein stability and function.
    Mol Cell Biol. 2000 Jul;20(14):5010-8 PMID: 10866658
  5. The FHA domain mediates phosphoprotein interactions.
    J Cell Sci. 2000 Dec;113 Pt 23:4143-9 PMID: 11069759
  6. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.
    Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):136-41 PMID: 11134523
  7. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
    Oncogene. 2001 Nov 8;20(51):7524-35 PMID: 11709724
  8. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Annu Rev Biochem. 2001;70:247-79 PMID: 11395408
  9. The FHA domain.
    FEBS Lett. 2002 Feb 20;513(1):58-66 PMID: 11911881
  10. Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration.
    J Biol Chem. 2002 Jul 12;277(28):25446-56 PMID: 11948183
  11. Direct identification of PTEN phosphorylation sites.
    FEBS Lett. 2002 Sep 25;528(1-3):145-53 PMID: 12297295
  12. Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation.
    FEBS Lett. 2003 Feb 11;536(1-3):180-6 PMID: 12586360
  13. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.
    Cancer Cell. 2003 Feb;3(2):117-30 PMID: 12620407
  14. PTEN: one gene, many syndromes.
    Hum Mutat. 2003 Sep;22(3):183-98 PMID: 12938083
  15. Phosphatases in cell-matrix adhesion and migration.
    Nat Rev Mol Cell Biol. 2003 Sep;4(9):700-11 PMID: 14506473
  16. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
    Science. 2004 Feb 20;303(5661):1179-81 PMID: 14976311
  17. Human MCRS2, a cell-cycle-dependent protein, associates with LPTS/PinX1 and reduces the telomere length.
    Biochem Biophys Res Commun. 2004 Apr 16;316(4):1116-23 PMID: 15044100
  18. The 58-kDa microspherule protein (MSP58), a nucleolar protein, interacts with nucleolar protein p120.
    Eur J Biochem. 1998 May 1;253(3):734-42 PMID: 9654073
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2005-02-22
Epub
2005-00-19
Pages
2703-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC549467
Subset
IM
Grants
NCI NIH HHS · P01 CA095616 · United States
NCI NIH HHS · CA95616 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com